Frontlight ResearchEarly access
Trial site
Sun Valley Research Center, Inc.
- 2running trials
- 6closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Mild cognitive impairment2 trials
- Phase
- Phase 36 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Completed4 trials
- Terminated2 trials
- Active, not recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Cassava Sciences, Inc.3 trials
- Hoffmann-La Roche2 trials
- Biohaven Pharmaceuticals, Inc.1 trial
- Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial
- Shire1 trial
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
- Mild cognitive impairment1 recruiting
Closed trials
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Completed
Completed
Terminated
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
Completed
Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients
Completed
A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
Site data: ClinicalTrials.govUpdated 15 Nov 2026